| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36b19bce8760e32c233f01c03e6406f8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate |
2000-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe91bd9ac7c1091789e6c6179ed7ee64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35457cb23e6677b69fb5ac8d1aeea974 |
| publicationDate |
2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2352633-A |
| titleOfInvention |
An anaesthetic formulation comprising a NMDA antagonist and an alpha-2 adrenergic agonist |
| abstract |
An anaesthetic formulation or a pharmaceutical composition comprising an NMDA antagonist and an alpha-2 adrenergic agonist is claimed. The NMDA antagonist can be xenon, whilst the alpha-2 adrenergic agonist can be dexmedetomidine. The anaesthetic can be a liquid or a lipid emulsion, administered intravenously, neuraxially or transdermally. Also claimed are methods of inducing anaesthesia or treatment by administering the formulation to a subject. |
| priorityDate |
1999-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |